Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

5.91
Delayed Data
As of Jan 20
 -0.50 / -7.80%
Today’s Change
2.50
Today|||52-Week Range
6.97
-2.96%
Year-to-Date
Synergy Pharmaceuticals Consolidating Recent Gains
Jan 20 / TheStreet.com - Paid Partner Content
5 Biotech Stocks You'll Want to Watch in the 1st Quarter
Jan 18 / MotleyFool.com - Paid Partner Content
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
Jan 20 / TheStreet.com - Paid Partner Content
Biotech Sector to See M&A, Earnings Action
Jan 17 / TheStreet.com - Paid Partner Content
Synergy (SGYP) Trulance Wins FDA Approval for Constipation
Jan 20 / Zacks.com - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
Your Pinch Hitter Kicks Off the Day
Jan 20 / TheStreet.com - Paid Partner Content
3 Little-Known Pharmaceutical Companies to Put on Your Radar
Jan 11 / MotleyFool.com - Paid Partner Content
Futures, Asia Mixed as Investors Ponder the New President
Jan 19 / TheStreet.com - Paid Partner Content
Zacks.com featured highlights: Beazer Homes USA, EnerSys, Greenhill, Synergy Pharmace...
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.41
Today’s open6.57
Day’s range5.76 - 6.71
Volume20,115,105
Average volume (3 months)4,281,219
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-8.82%
Earnings growth (this year)+10.28%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.55-2.55%
TXMDTherapeuticsMD Inc-0.16-2.85%
RGENRepligen Corp+0.21+0.69%
DEPODepomed Inc-0.26-1.44%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$117.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Gary S. Jacob
Senior Vice President-
Clinical Operations
Laura Barrow
Corporate headquarters
New York, New York

Forecasts


Search for Jobs